Uber Images / iStock
IPG, a provider of device benefit management solutions, has partnered with Lima Corporate, a global medical device company providing reconstructive and fixation orthopaedic solutions.
With a national footprint and focus on the commercial health care market, IPG enables high quality, cost effective surgical care and supports the delivery of value-based care for high cost surgical procedures for their health plan clients. This partnership creates significant opportunities to improve surgical outcomes, while reducing overall healthcare costs.
“Lima Corporate is enthusiastic to initiate this collaboration with IPG as it represents a paradigm shift in the medical device market in the US while maintaining access to state-of-the-art devices. Through this agreement, Lima is able to provide key technology, such as our Trabecular Titanium technology used in our hip and shoulder portfolio, which are the only 3D printed devices with 10-years of clinical follow-up,” said Luigi Ferrari, CEO of Lima Corporate.
By bringing transparency, contracting strategy, analytics and surgical expertise related to the delivery of device-intensive surgical procedures, IPG enables surgeons and facilities to successfully make value-based care delivery decisions that drive quality and affordability around surgical procedures through device selection and site of care optimization. As IPG continues to execute on its manufacturer partnership strategy with firms who strategically align with this objective, Lima was identified as an excellent fit.
“IPG is excited about the opportunity to work closely with Lima to bring their high-value technology to IPG’s health plan clients and patients,” said Vince Coppola, president and CEO of IPG. “This relationship will further expand our mission to bring high quality, cost effective surgical solutions to the US healthcare market.”
IPG, Lima Corporate, US
